AAAAAA
Results:
1-9
|
Results: 9
Authors:
Marty, M
Fumoleau, P
Adenis, A
Rousseau, Y
Merrouche, Y
Robinet, G
Senac, I
Puozzo, C
Citation: M. Marty et al., Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors, ANN ONCOL, 12(11), 2001, pp. 1643-1649
Authors:
Adenis, A
Bonneterre, J
Bonneterre, ME
Pion, JM
Vanlemmens, L
Gladieff, L
de Lafontan, B
Martel, P
Mihura, J
Roche, H
Gedouin, D
Kerbrat, P
Lesimple, T
Bremond, A
Devaux, Y
Delecroix, V
Fumoleau, P
Maugard-Louboutin, C
Namer, M
Goudier, MJ
Morice, F
Montcuquet, P
Schraub, S
Coudert, B
Fargeot, P
de Gislain, C
Mayer, F
Bastit, P
Chevallier, B
Grandgirard, A
Monnier, A
Sun, X
Clavere, P
Ollivier, JP
Rhein, B
Roullet, B
Datchary, J
Audhuy, B
Barats, JC
Kohser, F
Dides, S
Ramos, R
Cattan, A
Eymard, JC
Pourny, C
Weber, B
de Laroche, G
Pichon, A
Seffert, P
Hayat, M
Zambon, E
Chollet, P
Van Praagh, I
Citation: A. Adenis et al., Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French adjuvant study group 05 randomized trial, J CL ONCOL, 19(3), 2001, pp. 602-611
Authors:
Adenis, A
Catala, P
Mirabel, X
Triboulet, JP
Citation: A. Adenis et al., Esophageal cancers, B CANCER, 88(10), 2001, pp. 965-983
Authors:
Adenis, A
Conroy, T
Lassen, P
Merrouche, Y
Monges, G
Rivoire, M
Rougier, P
Ruggieri-Pignon, S
Citation: A. Adenis et al., Carcinoma of the colon, BR J CANC, 84, 2001, pp. 65-68
Authors:
Rougier, P
Adenis, A
Ducreux, M
de Forni, M
Bonneterre, J
Dembak, M
Clouet, P
Lebecq, A
Baille, P
Lefresne-Soulas, F
Blanc, C
Armand, JP
Citation: P. Rougier et al., A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma, EUR J CANC, 36(8), 2000, pp. 1016-1025
Authors:
Ychou, M
Douillard, JY
Rougier, P
Adenis, A
Mousseau, M
Dufour, P
Wendling, JL
Burki, F
Mignard, D
Marty, M
Citation: M. Ychou et al., Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (irinotecan) for advanced 5-FU-resistant colorectal cancer - An open-label multicenterphase II study, AM J CL ONC, 23(2), 2000, pp. 143-148
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults
Authors:
Roche, H
Cure, H
Adenis, A
Fargeot, P
Terret, C
Lentz, MA
Madelmont, JC
Fumoleau, P
Hanauske, A
Chollet, P
Citation: H. Roche et al., Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults, J NEURO-ONC, 49(2), 2000, pp. 141-145
Authors:
Conroy, T
Paillot, B
Adenis, A
Citation: T. Conroy et al., New drugs in gastrointestinal oncology. Current status and future directions, GASTRO CL B, 23(11), 1999, pp. 1145-1165
Authors:
Kurtz, JE
Trillet-Lenoir, V
Bugat, R
Negrier, S
Adenis, A
Kayitalire, L
Ripoche, V
Dufour, P
Citation: Je. Kurtz et al., Compassionate use of gemcitabine in advanced pancreatic cancer: a French multicentric study, B CANCER, 86(2), 1999, pp. 202-206
Risultati:
1-9
|